KORU Medical Systems Analyst Ratings
KORU Medical Systems Analyst Ratings
While ratings are subjective and will change, the latest KORU Medical Systems (KRMD) rating was a upgraded with a price target of $3.00 to $3.50. The current price KORU Medical Systems (KRMD) is trading at is $2.31, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2022 | 51.52% | Piper Sandler | $3 → $3.5 | Upgrades | Neutral → Overweight |
| 01/26/2021 | 116.45% | Canaccord Genuity | → $5 | Downgrades | Buy → Hold |
| 01/26/2021 | 94.81% | Piper Sandler | $9 → $4.5 | Downgrades | Overweight → Neutral |
| 11/05/2020 | 332.9% | Canaccord Genuity | $13 → $10 | Maintains | Buy |
| 07/16/2020 | 462.77% | Canaccord Genuity | → $13 | Initiates Coverage On | → Buy |
| 06/24/2020 | 419.48% | Piper Sandler | → $12 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 10 月 11 日 | 51.52% | 派珀·桑德勒 | 3 美元 → 3.5 美元 | 升級 | 中性 → 超重 |
| 2021 年 1 月 26 日 | 116.45% | Canaccord Genu | → 5 美元 | 降級 | 買入 → 持有 |
| 2021 年 1 月 26 日 | 94.81% | 派珀·桑德勒 | 9 美元 → 4.5 美元 | 降級 | 超重 → 中性 |
| 2020 年 5 月 11 日 | 332.9% | Canaccord Genu | 13 美元 → 10 美元 | 維持 | 購買 |
| 07/16/2020 | 462.77% | Canaccord Genu | → 13 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 06/24/2020 | 419.48% | 派珀·桑德勒 | → 12 美元 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for KORU Medical Systems (KRMD)?
KORU 醫療系統（KRMD）的目標價格是多少？
The latest price target for KORU Medical Systems (NASDAQ: KRMD) was reported by Piper Sandler on November 10, 2022. The analyst firm set a price target for $3.50 expecting KRMD to rise to within 12 months (a possible 51.52% upside). 1 analyst firms have reported ratings in the last year.
派珀·桑德勒於2022年11月10日公佈了KORU醫療系統（納斯達克股票代碼：KRMD）的最新目標股價。該分析公司將目標股價定爲3.50美元，預計KRMD將在12個月內升至12個月內（可能上漲51.52％）。1家分析公司去年公佈了評級。
What is the most recent analyst rating for KORU Medical Systems (KRMD)?
KORU Medical Systems（KRMD）的最新分析師評級是多少？
The latest analyst rating for KORU Medical Systems (NASDAQ: KRMD) was provided by Piper Sandler, and KORU Medical Systems upgraded their overweight rating.
派珀·桑德勒對KORU Medical Systems（納斯達克股票代碼：KRMD）的最新分析師評級由派珀·桑德勒提供，KORU Medical Systems上調了增持評級。
When is the next analyst rating going to be posted or updated for KORU Medical Systems (KRMD)?
KORU Medical Systems（KRMD）的下一次分析師評級將在何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KORU Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KORU Medical Systems was filed on November 10, 2022 so you should expect the next rating to be made available sometime around November 10, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與KORU Medical Systems的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。KORU Medical Systems的最新評級是在2022年11月10日發佈的，因此您應該預計下一個評級將在2023年11月10日左右公佈。
Is the Analyst Rating KORU Medical Systems (KRMD) correct?
分析師對KORU Medical Systems（KRMD）的評級是否正確？
While ratings are subjective and will change, the latest KORU Medical Systems (KRMD) rating was a upgraded with a price target of $3.00 to $3.50. The current price KORU Medical Systems (KRMD) is trading at is $2.31, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的KORU醫療系統（KRMD）評級已上調，目標股價爲3.00美元，至3.50美元。KORU Medical Systems（KRMD）目前的交易價格爲2.31美元，超出了分析師的預期區間。